Back
AN2 Therapeutics Vs. Cidara Therapeutics Industry Stock Comparison
Sell
48
ANTX
AN2 Therapeutics
Last Price:
1.35
Seasonality Move:
-36.32%
Buy
85
CDTX
Cidara Therapeutics
Last Price:
20.68
Seasonality Move:
10.99%
Sell
48
AN2 Therapeutics (ANTX)
is a Sell
Is AN2 Therapeutics a Buy, Sell or Hold?
- The current AN2 Therapeutics [ANTX] share price is $1.34. The Score for ANTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- ANTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
85
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
- The current Cidara Therapeutics [CDTX] share price is $20.40. The Score for CDTX is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
- CDTX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ANTX Stock Price Chart
What is AN2 Therapeutics's stock price today?
-
The AN2 Therapeutics share price today is $1.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANTX is experiencing slight buying pressure.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $20.40
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ANTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 72.02 | Buy |
| Chaikin Money Flow: | 4705 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.02 - 1.18) | Buy |
| Bollinger Bands (100): | (0.78 - 2.14) | Sell |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.46 | Buy |
| Relative Strength Index (14 RSI): | 87.39 | Buy |
| Chaikin Money Flow: | 119404 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.7 - 15.64) | Buy |
| Bollinger Bands (100): | (10.76 - 13.72) | Buy |
ANTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.12 | Buy |
| 20-day SMA: | 1.1 | Buy |
| 50-day SMA: | 1.07 | Buy |
| 200-day SMA: | 2.15 | Sell |
| 8-day EMA: | 1.17 | Buy |
| 20-day EMA: | 1.12 | Buy |
| 50-day EMA: | 1.16 | Buy |
| 200-day EMA: | 3.51 | Sell |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.79 | Buy |
| 20-day SMA: | 14.21 | Buy |
| 50-day SMA: | 12.3 | Buy |
| 200-day SMA: | 13.05 | Buy |
| 8-day EMA: | 16.36 | Buy |
| 20-day EMA: | 14.59 | Buy |
| 50-day EMA: | 13.14 | Buy |
| 200-day EMA: | 13.37 | Buy |
AN2 Therapeutics Earnings Growth & ANTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.49 per share, and an increase next year of $0.29 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.97 per share, a decrease next quarter of $0.00 per share, a decrease this year of $18.96 per share, and an increase next year of $15.14 per share.
AN2 Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||